Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia
J. A. Charlesworth, … , P. J. Lachmann, D. K. Peters
J. A. Charlesworth, … , P. J. Lachmann, D. K. Peters
Published June 1, 1974
Citation Information: J Clin Invest. 1974;53(6):1578-1587. https://doi.org/10.1172/JCI107708.
View: Text | PDF
Research Article

Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia

  • Text
  • PDF
Abstract

Metabolic studies using radioiodine-labeled third component of complement (C3) and the glycine-rich β glycoprotein (GBG), a major component of the C3b-feedback pathway, were undertaken in normal subjects, in 22 patients with evidence of complement activation, and in 11 patients with various renal diseases without evidence of complement activation. In seven normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per h. and extravascular/intravascular distribution ratios from 0.81 to 1.31. In patients with reduced plasma C3, both increased C3 fractional catabolic rates and reduced C3 synthesis rates were observed, and in some patients there was evidence of increased extravascular distribution of the protein. GBG catabolism was usually increased when there was evidence of C3 activation, presumably reflecting activation of the C3b-feedback; but GBG turnover was normal or only slightly accelerated in some patients with accelerated C3 catabolism and profound hypocomplementemia, suggesting that reduced C3 synthesis had limited activation of the C3b-feedback.

Authors

J. A. Charlesworth, D. Gwyn Williams, E. Sherington, P. J. Lachmann, D. K. Peters

×

Total citations by year

Year: 2017 2016 2015 2012 2011 2008 2006 2005 2004 2001 1999 1998 1997 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 Total
Citations: 2 1 1 1 1 3 1 1 1 2 1 1 1 2 1 3 4 6 1 8 3 3 6 5 11 5 8 4 4 9 5 14 11 4 3 137
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (137)

Title and authors Publication Year
Generation of complement protein C3 deficient pigs by CRISPR/Cas9-mediated gene targeting
W Zhang, G Wang, Y Wang, Y Jin, L Zhao, Q Xiong, L Zhang, L Mou, R Li, H Yang, Y Dai
Scientific Reports 2017
The Clinical Chemistry of Laboratory Animals
DM Kurtz, GS Travlos
The Clinical Chemistry of Laboratory Animals 2017
Self-nonself discrimination by the complement system
S Meri
FEBS Letters 2016
A Quantitative Lateral Flow Assay to Detect Complement Activation in Blood
EC Schramm, NR Staten, Z Zhang, SS Bruce, C Kellner, JP Atkinson, VC Kyttaris, GC Tsokos, M Petri, ES Connolly, PK Olson
Analytical Biochemistry 2015
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Complement Activation During Liver Transplantation-Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome : Complement Activation in Liver Transplantation
AR Koskinen, E Tukiainen, J Arola, A Nordin, HK Höckerstedt, B Nilsson, H Isoniemi, TS Jokiranta
American Journal of Transplantation 2011
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice
Kirsten L. Rose Danielle Paixao-Cavalcante Jennifer Fish Anthony P. Manderson Talat Malik Anne E. Bygrave Tao Lin Steven H. Sacks Mark J. Walport H. Terence Cook Marina Botto Matthew C. Pickering
Journal of Clinical Investigation 2008
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
A hemolytic method for the measurement of nephritic factor
CD West
Journal of Immunological Methods 2008
Systemic Lupus Erythematosus
M Petri
JCR: Journal of Clinical Rheumatology 2006
The role of biomarkers in the assessment of lupus
JT Merrill, JP Buyon
Best Practice & Research Clinical Rheumatology 2005
Clinical Features and Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy
A Misra, A Peethambaram, A Garg
Medicine 2004
Complement in renal disease
JA Charlesworth, PW Peake, BA Pussell, JH Erlich
Nephrology 2001
Vascular Manifestations of Systemic Autoimmune Diseases
C Kallenberg, JC Tervaert
Vascular Manifestations of Systemic Autoimmune Diseases 2001
Molecular and Cellular Basis of Inflammation
CN Serhan, PA Ward
1999
INFECTION IN SYSTEMIC LUPUS ERYTHEMATOSUS
M Petri
Rheumatic Disease Clinics of North America 1998
Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies
L Skattum, U Martensson, AG Sjöholm
Journal of Internal Medicine 1997
Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia
CD West, AJ McAdams
American Journal of Kidney Diseases 1995
Clinical utility of complement assessment
AE Ahmed, JB Peter
Clinical and diagnostic laboratory immunology 1995
Complement activation by cellulosic dialysis membranes
A Innes, AM Farrell, RP Burden, AG Morgan, RJ Powell
Journal of clinical pathology 1994
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus
E Röther, B Lang, R Coldewey, K Hartung, HH Peter
Clinical Rheumatology 1993
Molecular analysis of C3 allotypes in patients with nephritic factor
JE Finn, PW Mathieson
Clinical & Experimental Immunology 1993
Molecular analysis of C3 allotypes in patients with nephritic factor.
Finn JE, Mathieson PW
Clinical & Experimental Immunology 1993
Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritis factor and persistently low complement C3 and C5
SA Hulton, RA Risdon, MJ Dillon
Pediatric Nephrology 1992
Assessment of complement activation in vivo
M Oppermann, U Höpken, O Götze
Immunopharmacology 1992
The Complement System
A Agostoni, M Cicardi, M Gardinali, L Bergamaschini
International journal of immunopathology and pharmacology 1992
Idiopathic membranoproliferative glomerulonephritis in childhood
CD West
Pediatric Nephrology 1992
C3 Activation Products, C3 Containing Immune Complexes, the Terminal Complement Complex and Native C9 in Patients with Rheumatoid Arthritis
Ü Ölmez, P Garred, TE Mollnes, M Harboe, HB Berntzen, E Munthe
Scandinavian Journal of Rheumatology 1991
INHERITED DEFICIENCIES OF COMPLEMENT PROTEINS : with special reference to congenital deficiency of the regulatory protein factor I
JE RASMUSSEN
APMIS 1991
INHERITED DEFICIENCIES OF COMPLEMENT PROTEINS: with special reference to congenital deficiency of the regulatory protein factor I
JE RASMUSSEN
APMIS 1991
Relative Value of Serum C3 and C4 Levels in Predicting Relapse in Systemic Lupus Erythematosus
CD West
American Journal of Kidney Diseases 1991
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease
ET Littleton, L Bevis, LJ Hansen, M Peakman, AP Mowat, G Mieli-Vergani, D Vergani
Journal of clinical pathology 1991
Immunology of Renal Disease
CD Pusey
1991
Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis
PN Hawkins, R Wootton, MB Pepys
Journal of Clinical Investigation 1990
The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus
N Negoro, M Okamura, T Takeda, S Koda, K Amatsu, T Inoue, JG Curd, Y Kanayama
Arthritis & Rheumatism 1989
Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity
LD Kerr, BR Adelsberg, P Schulman, H Spiera
Arthritis & Rheumatism 1989
Activation of the complement system in systemic sclerosis. Relationship to clinical severity
G Senaldi, S Lupoli, D Vergani, CM Black
Arthritis & Rheumatism 1989
THE METABOLISM OF C3 AND C4 IN PATIENTS WITH IMMUNE COMPLEXES AND NORMAL COMPLEMENT LEVELS
JA Charlesworth, PW Peake, J Golding, BA Pussell, V Timmermans, I Wicks, D Wakefield
Australian and New Zealand Journal of Medicine 1989
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
M Peakman, G Senaldi, D Vergani
Journal of clinical pathology 1989
Differences in the metabolism of C4 isotypes in patients with complement activation
PW Peake, BA Pussell, JA Charlesworth, L Gavrilovic, V Timmermans
Clinical & Experimental Immunology 1989
A new method for the estimation of C3d
SS Asghar, B Schraag, AH Backhaus, I Zorn, GT Venneker, AJ Hannema
Journal of Immunological Methods 1989
Serum terminal complement component levels in hypocomplementemic glomerulonephritides
CW Clardy, J Forristal, CF Strife, CD West
Clinical Immunology and Immunopathology 1989
Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B
M Oppermann, M Haubitz, E Quentin, O Götze
Klinische Wochenschrift 1988
Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis
P Hopkins, HM Belmont, J Buyon, M Philips, G Weissmann, SB Abramson
Arthritis & Rheumatism 1988
Hereditary C3 hypocomplementemia in the rabbit
M Komatsu, K Yamamoto, Y Nakano, M Nakazawa, A Ozawa, H Mikami, M Tomita, S Migita
Immunology 1988
The complement system in Type 1 (insulin-dependent) diabetes
JA Charlesworth, V Timmermans, J Golding, LV Campbell, PW Peake, BA Pussell, D Wakefield, N Howard
Diabetologia 1987
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay
M Peakman, A Lobo-Yeo, G Senaldi, M Nilsson, DE Tee, D Vergani
Journal of Immunological Methods 1987
Quantiation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation
FB Waldo, CD West
Clinical Immunology and Immunopathology 1987
Hypocomplementemia with low Cls-Cl inhibitor complex in systemic lupus erythematosus
MD Lockshin, T Qamar, P Redecha, PC Harpel
Arthritis & Rheumatism 1986
Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen
Y Kanayama, Y Kurata, R McMillan, JD Tamerius, N Negoro, JG Curd
Journal of Immunological Methods 1986
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
TE Mollnes, T Lea, OJ Mellbye, J Pahle, Ø Grand, M Harboe
Arthritis & Rheumatism 1986
Membranoproliferative Glomerulonephritis, Type II and Partial Lipodystrophy in an Adult
J Pollock, B Wood, JP Kelly
American Journal of Kidney Diseases 1986
Complement in the Pathophysiology and Diagnosis of Human Diseases
AP Dalmasso
Critical Reviews in Clinical Laboratory Sciences 1986
Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course
AJ Swaak, A van Rooyen, C Vogelaar, M Pillay, E Hack
Rheumatology International 1986
Human fibronectin metabolism
BA Pussell, PW Peake, MA Brown, JA Charlesworth
Journal of Clinical Investigation 1985
GENETICALLY DETERMINED LOW C4: A PREDISPOSING FACTOR TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
D Vergani, VF Larcher, ET Davies, L Wells, BA Nasaruddin, G Mieli-Vergani, AP Mowat
The Lancet 1985
Dual Cutaneous Reactions to Anti-Human IgE; No Change in Plasma Level of the Split Product Complement C3d or Effect of Heparin
R Gröonneberg
Allergy 1985
Complement levels and C3 breakdown products in open-heart surgery: association of C3 conversion with the postpericardiotomy syndrome
S Meri, K Verkkala, A Miettinen, V Valtonen, E Linder
Clinical & Experimental Immunology 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Complement Activation in Renal Disease
CD West
Renal Failure 1984
C3 metabolism in acute glomerulonephritis: Implications for sites of complement activation
ZH Endre, BA Pussell, JA Charlesworth, HM Coovadia, YK Seedat
Kidney International 1984
Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d
I Brandslund, B Teisner, PH Petersen, SE Svehag
Scandinavian Journal of Clinical & Laboratory Investigation 1984
CIRCULATING IMMUNE COMPLEXES AND COMPLEMENT BREAKDOWN PRODUCT C3d IN GLOMERULONEPHRITIS AND KIDNEY TRANSPLANTATION
J Sølling
Acta Pathologica Microbiologica Scandinavica Series C: Immunology 1984
C3 NEPHRITIC FACTOR IN A PATIENT WITH RECURRENT NEISSERIA MENINGITIDIS INFECTIONS
B Teisner, P Elling, SE Svehag, L Poulsen, LU Lamm, A Sjöholm
Acta Pathologica Microbiologica Scandinavica Series C: Immunology 1984
Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus
D Adu, DG Williams
Clinical & Experimental Immunology 1984
Plasma C3d/C3 quotient as a parameter for in vivo complement activation
W Nürnberger, S Bhakdi
Journal of Immunological Methods 1984
The third complement factor (C3) and its in vivo cleavage products: Interaction with lectins and precipitation with polyethylene glycol
B Teisner, J Hau, SE Svehag, I Brandslund, TC Bøg-Hansen
Journal of Immunological Methods 1984
A simple method for quantitative measurement of C3d in human plasma
S Bhakdi, M Roth, W Nürnberger
Journal of Immunological Methods 1984
Cutaneous leishmaniasis: immune complex formation and necrosis in the acute phase
MJ Ridley, DS Ridley
British Journal of Experimental Pathology 1984
Pathophysiology of Plasma Protein Metabolism
G Mariani
1984
Breakdown Product of Factor B as an Index of Complement Activation in Lepromatous Leprosy and Its Relation with Bacillary Load
K Saha, V Sharma, AK Chakrabarty, VN Sehgal
Scandinavian Journal of Immunology 1983
Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor
RA Thompson, PL Yap, RB Brettle, RE Dunmow, H Chapel
Clinical & Experimental Immunology 1983
A single step immunoelectrophoresis method for the quantitation of complement C3c in biological fluids
A Berkowicz, J Rosenkvist, H Sørensen
Journal of Immunological Methods 1983
The in vivo metabolism of C3 in human glomerulonephritis and after renal transplantation
L Brinch, I Aakesson, P Teisberg, E Enger
Scandinavian Journal of Clinical & Laboratory Investigation 1983
Clinical application of a new nephelometric technique to measure complement activation
D Vergani, L Bevis, BA Nasaruddin, G Mieli-Vergani, DE Tee
Journal of clinical pathology 1983
Complement Deficiency and Disease
JA Charlesworth, BA Pussell
Australian and New Zealand Journal of Medicine 1982
Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity
RK Mallya, D Vergani, DE Tee, L Bevis, FC de Beer, H Berry, ED Hamilton, BE Mace, MB Pepys
Clinical & Experimental Immunology 1982
Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4
MJ Sinosich, B Teisner, I Brandslund, M Fisher, JG Grudzinskas
Journal of Immunological Methods 1982
Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis
BE Bourke, IK Moss, RN Maini
Journal of Immunological Methods 1982
Circulating C3, C4, and C3 Split Products (C3c and C3d) During Normal Pregnancy*
B Teisner, J Hau, M Tucker, J Lahood, JG Grudzinskas
American Journal of Reproductive Immunology 1982
Loculated Pleural Empyema: Identification of Complement Breakdown Products in Contiguous Sterile Pleural Fluid
PD Lew, LH Perrin, FA Waldvogel, PH Lambert
Scandinavian Journal of Infectious Diseases 1982
Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes
AJ Swaak, A Hannema, C Vogelaar, FA Boom, L van Es, R van Aalst, LW van Eps
Rheumatology International 1982
The in-vivo metabolism of C3 in ankylosing spondylitis
L Brinch, O Vinje, P Teisberg, OJ Mellbye, I Aakesson
Annals of the rheumatic diseases 1982
Molecular aspects of complement activation
K Whaley, A Ferguson
Molecular Aspects of Medicine 1981
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin
RA Thompson, MH Winterborn
Clinical & Experimental Immunology 1981
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma
I Brandslund, HC Siersted, SE Svehag, B Teisner
Journal of Immunological Methods 1981
Immunological Aspects of Rheumatology
WC Dick
1981
Clinical Significance of Serum Complement Levels in Post-streptococcal Acute Glomerulonephritis
Y Koitabashi, T Maruyama, T Baba
Pediatrics International 1980
Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins
MT Aguado, LH Perrin, R Ramirez, PA Miescher, PH Lambert
Clinical & Experimental Immunology 1980
Change in Serum Properdin Factor B Phenotype Following Human Orthoptic Liver Transplantation
G Hauptmann, MM Tongio, J Klein, S Mayer, J Cinqualbre, B Jeanblanc, R Kieny
Immunobiology 1980
The Metabolism of C3 in Adult Coeliac Disease
L Brinch, P Teisberg, O Fausa, I ÅKesson
Scandinavian Journal of Gastroenterology 1980
Complement activation in pneumonia
U Nydegger, JJ Farquet, R Zubler, PH Lambert, PA Miescher
Medical Microbiology and Immunology 1979
Circulating immune complexes and C3d in human parasitosis
PJ Verroust, C Adam, MD Smith, D Richard-Lenoble, O Kourilsky, LJ Morel-Maroger
Kidney International 1979
Complement activation profiles in disease
DL Brown
Journal of clinical pathology. Supplement (Royal College of Pathologists) 1979
Complement activation in asymptomatic patients with sickle cell anaemia
WA Wilson, EJ Thomas, JG Sissons
Clinical & Experimental Immunology 1979
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus
K Whaley, PH Schur, S Ruddy
Clinical & Experimental Immunology 1979
Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis
K Whaley, D Ward, S Ruddy
Clinical & Experimental Immunology 1979
Experimental immune glomerulonephritis induced in the rabbit with streptococcal vaccine
B Bellon, J Kuhn, K Ayed, JF Girard, P Druet
Clinical & Experimental Immunology 1979
Metabolism of human beta 1H: studies in man and experimental animals
JA Charlesworth, DM Scott, BA Pussell, DK Peters
Clinical & Experimental Immunology 1979
Metabolic studies of C3 in man
L Brinch, P Teisberg, I Aakesson
Journal of Immunological Methods 1979
Identification of nephritic factor as an immunoglobulin
DG Williams, A Bartlett, P Duffus
Clinical & Experimental Immunology 1978
Hypocomplementemia in a newborn infant caused by placental transfer of C3 nephritic factor
Y Kim, Y Shvil, AF Michael
The Journal of Pediatrics 1978
Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN)
M Levy, MC Gubler, M Sich, A Beziau, R Habib
Clinical Immunology and Immunopathology 1978
Complement in cystic fibrosis
M Gtz, G Lubec
European Journal of Pediatrics 1978
Immune Complexes and the Rheumatic Diseases
PH Lambert, P Casali
Clinics in rheumatic diseases 1978
Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation
JG Sissons, J Liebowitch, N Amos, DK Peters
Journal of Clinical Investigation 1977
Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity
UE Nydegger, RH Zubler, R Gabay, G Joliat, CH Karagevrekis, PH Lambert, PA Miescher
Journal of Clinical Investigation 1977
INHERITED DEFICIENCIES OF COMPLEMENT IN MAN
TL Ray, KD Wuepper
International Journal of Dermatology 1977
Serum immune complexes in membranoproliferative and other glomerulonephritides
YM Ooi, EH Vallota, CD West
Kidney International 1977
The in Vivo Metabolism of the Third Component of Complement in Systemic Lupus Erythematosus
LD Petz, R Powers, JR Fries, NR Cooper, HR Holman
Arthritis & Rheumatism 1977
Pathways of complement activation in chronic discoid lupus
MA Schrager, NF Rothfield
Arthritis & Rheumatism 1977
The Nail Patella Syndrome-A Report of a Family
BA Pussell, JA Charlesworth, GJ Macdonald, WC Baker
Australian and New Zealand Journal of Medicine 1977
The Complement System in Infectious Mononucleosis
JA Charlesworth, BA Pussell, LP Roy, S Lawrence, MR Robertson
Australian and New Zealand Journal of Medicine 1977
COMPLEMENT ACTIVATION IN MIGRAINE
GD Lord, TW Duckworth, JA Charlesworth
The Lancet 1977
Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis
J Forristal, K Iitaka, EH Vallota, CD West
Clinical & Experimental Immunology 1977
Acute hepatitis: significance of changes in complement components
JA Charlesworth, S Lawrence, PA Worsdall, LP Roy, CR Boughton
Clinical & Experimental Immunology 1977
Normal complement in early poststreptococcal glomerulonephritis
RH McLean, MA Schrager, NF Rothfield, MA Berman
British medical journal 1977
Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus
RI Rynes, RE Urizar, RJ Pickering
The American Journal of Medicine 1977
Disorders of the complement system in lipodystrophy
MM Ipp, JO Minta, EW Gelfand
Clinical Immunology and Immunopathology 1977
Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus
MA Schrager, NF Rothfield
Journal of Clinical Investigation 1976
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase
K Whaley, PH Schur, S Ruddy
Journal of Clinical Investigation 1976
Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis
CD West
Kidney International 1976
Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis
WA Border, CB Wilson, O Götze
Kidney International 1976
Measles infection. Involvement of the complement system
JA Charlesworth, BA Pussell, LP Roy, MR Robertson, J Beveridge
Clinical & Experimental Immunology 1976
C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus
JH Wild, NJ Zvaifler, HJ Müller-Eberhard, CB Wilson
Clinical & Experimental Immunology 1976
Activation of the alternative complement pathway in systemic lupus erythematosus
MR Wilson, CM Arroyave, RM Nakamura, JH Vaughan, EM Tan
Clinical & Experimental Immunology 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro
N Amos, JG Sissons, JF Girard, PJ Lachmann, DK Peters
Clinical & Experimental Immunology 1976
Detection of complement activation by counterimmunoelectrophoresis (CIE)
CM Arroyave, EM Tan
Journal of Immunological Methods 1976
The Complement Abnormalities of Lipodystrophy
JG Sissons, RJ West, J Fallows, DG Williams, BJ Boucher, N Amos, DK Peters
New England Journal of Medicine 1976
Complement and the Clinician
DG Palmer
Australian and New Zealand Journal of Medicine 1976
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis
LH Perrin, PH Lambert, PA Miescher
Journal of Clinical Investigation 1975
Metabolism of properdin in normal subjects and patients with renal disease
JB Ziegler, FS Rosen, CA Alper, W Grupe, IH Lepow
Journal of Clinical Investigation 1975
Studies in vivo of cobra factor and murine C3
MB Pepys
Immunology 1975
Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives
RS Tedder, M Nelson, V Eisen
British Journal of Experimental Pathology 1975
SIGNIFICANCE OF COMPLEMENT-POSITIVE COOMBS TEST IN PATIENTS WITH GLOMERULAR DISEASE
O Kourilsky, JP Lucas, C Poyau-Lemaux, G Neuilly, G Richet
The Lancet 1974
SKIN LESIONS, ANGIO-ŒDEMA, AND HYPOCOMPLEMENTÆMIA
JG Sissons, DK Peters, DG Williams, JM Boulton-Jones, HJ Goldsmith
The Lancet 1974
Studies of serum complement in the hypocomplementaemic nephritides
DG Williams, DK Peters, J Fallows, A Petrie, O Kourilsky, L Morel-Maroger, JS Cameron
Clinical & Experimental Immunology 1974

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts